SCHEMBL13449296

SCHEMBL13449296

COc1cc(C=O)ccc1NC(=O)c1cc(F)ccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 3/20 0.54
KMT2A Q03164 3/20 0.54
MAPT P10636 3/20 0.53
POLB P06746 2/20 0.53
GAA P10253 1/20 0.53
RECQL P46063 1/20 0.53
PYGL P06737 5/20 0.51
SMN1; SMN2 Q16637 5/20 0.49
RORC P51449 1/20 0.49
HPGD P15428 1/20 0.48
GRM4 Q14833 4/20 0.47
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
TAS1R2 Q8TE23 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13449297 0.88 MAPT (0.53) ALDH1A1KMT2AMAPTGAATAS1R3
SCHEMBL3134272 0.82 ALDH1A1 (0.58) ALDH1A1KDM4EKMT2AMAPTPOLB
SCHEMBL3135239 0.82 PYGL (0.69) ALDH1A1KDM4EKMT2AMAPTPOLB
SCHEMBL3138705 0.82 PYGL (0.57) ALDH1A1KDM4EKMT2AMAPTPOLB
SCHEMBL8242777 0.81 MAPT (0.53) ALDH1A1KDM4EKMT2AMAPTPOLB
SCHEMBL4971900 0.81 POLB (0.53) ALDH1A1KDM4EKMT2AMAPTPOLB
SCHEMBL8435221 0.81 PYGL (0.58) ALDH1A1KDM4EKMT2AMAPTPOLB
SCHEMBL6640602 0.77 ALDH1A1 (0.56) ALDH1A1KMT2AMAPTPOLBSMN1; SMN2
SCHEMBL20601617 0.75 PYGL (0.83) ALDH1A1KDM4EKMT2APYGLSMN1; SMN2
SCHEMBL28464698 0.75 CYP1A2 (0.51) ALDH1A1KDM4EKMT2AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687494-B2 Substituted spirobenzazepines JANSSEN PHARMACEUTICA NV (BE) 2010-03-30 US disclosed